Sage Therapeutics shares dive after Phase III trial of SRSE treatment fails primary endpoint 11:24 AM health No comments Sage Therapeutics shares dive after Phase III trial of SRSE treatment fails primary endpoint Proactive Investors UK Sage Therapeutics Gets a Dunce Hat 24/7 Wall St.Full coverage Share It Facebook Twitter LinkedIn BLOG AUTHOR Please add Follow him @ Linkedin | Instagram | Twitter
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.